Cardiovascular autonomic neuropathy in the course of diabetes - the review of actual knowledge.
Diabetic neuropathy, including autonomic cardiovascular neuropathy, is the most common chronic complication of diabetes. It causes serious health and social consequences, leading to a significant reduction of life expectancy in DM patients. Its development is initially asymptomatic and therefore often underestimated, and only the early detection of diabetic neuropathy gives a real chance to stop its progression and prevent irreversible damage to the nerves. The optimal glycemic control is the most important factor preventing the development of neuropathy, inhibiting its occurrence and progression. In the advanced stage, however, only symptomatic treatment remains. The article provides an overview of current knowledge about etiopathogenesis, therapy, symptoms and the latest clinical trials on NSN and DM.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
|---|---|
| Enthalten in: |
Postepy biochemii - 65(2019), 4 vom: 30. Dez., Seite 306-312 |
| Sprache: |
Polnisch |
|---|
| Weiterer Titel: |
Neuropatia autonomiczna układu sercowo-naczyniowego w przebiegu cukrzycy - aktualny stan wiedzy |
|---|
| Beteiligte Personen: |
Kieć-Wilk, Beata [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 03.02.2020 Date Revised 03.02.2020 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.18388/pb.2019_287 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM305435930 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM305435930 | ||
| 003 | DE-627 | ||
| 005 | 20231225121159.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||pol c | ||
| 024 | 7 | |a 10.18388/pb.2019_287 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1018.xml |
| 035 | |a (DE-627)NLM305435930 | ||
| 035 | |a (NLM)31945285 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a pol | ||
| 100 | 1 | |a Kieć-Wilk, Beata |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cardiovascular autonomic neuropathy in the course of diabetes - the review of actual knowledge. |
| 246 | 3 | 3 | |a Neuropatia autonomiczna układu sercowo-naczyniowego w przebiegu cukrzycy - aktualny stan wiedzy |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.02.2020 | ||
| 500 | |a Date Revised 03.02.2020 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Diabetic neuropathy, including autonomic cardiovascular neuropathy, is the most common chronic complication of diabetes. It causes serious health and social consequences, leading to a significant reduction of life expectancy in DM patients. Its development is initially asymptomatic and therefore often underestimated, and only the early detection of diabetic neuropathy gives a real chance to stop its progression and prevent irreversible damage to the nerves. The optimal glycemic control is the most important factor preventing the development of neuropathy, inhibiting its occurrence and progression. In the advanced stage, however, only symptomatic treatment remains. The article provides an overview of current knowledge about etiopathogenesis, therapy, symptoms and the latest clinical trials on NSN and DM | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Gastoł, Joanna |e verfasserin |4 aut | |
| 700 | 1 | |a Pawliński, Łukasz |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Postepy biochemii |d 1954 |g 65(2019), 4 vom: 30. Dez., Seite 306-312 |w (DE-627)NLM000034541 |x 0032-5422 |7 nnns |
| 773 | 1 | 8 | |g volume:65 |g year:2019 |g number:4 |g day:30 |g month:12 |g pages:306-312 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18388/pb.2019_287 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 65 |j 2019 |e 4 |b 30 |c 12 |h 306-312 | ||